Skip to ContentSkip to Navigation
Practical matters How to find us ing. B. Maas


PET Imaging with S-[C-11]Methyl-L-Cysteine and L-[Methyl-C-11]Methionine in Rat Models of Glioma, Glioma Radiotherapy, and Neuroinflammation

Contribution of neuroinflammation to changes in [C-11]flumazenil binding in the rat brain: Evaluation of the inflamed pons as reference tissue

Improved GMP-compliant multi-dose production and quality control of 6-[18F]fluoro-L-DOPA

Novel approach to repeated arterial blood sampling in small animal PET: Application in a test-retest study with the adenosine A1 receptor ligand [C-11]MPDX

Pridopidine selectively occupies sigma-1 rather than dopamine D2 receptors at behaviorally active doses

Comparison of the amino acid PET tracers S-[11C]methylcysteine ([11C]MCYS) and [11C]methionine ([11C]MET) for in vivo imaging of brain tumors

Contribution of activated microglia to changes in [11C]flumazenil binding in the rat brain. Evaluation of pons as reference tissue

First Clinical Results of (D)-F-18-Fluoromethyltyrosine (BAY 86-9596) PET/CT in Patients with Non Small Cell Lung Cancer and Head and Neck Squamous Cell Carcinoma

Validation of18F-DOPA quality control using UPLC®-MS

Positron emission tomography studies of human airways using an inhaled beta-adrenoceptor antagonist, S-11C-CGP 12388

Read more